Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at Hepion Pharmaceuticals Inc fell by 36.40m. Cash Flow from Financing totalled 4.49m or -- of revenues. In addition the company used 40.89m for operations while cash used for investing totalled 14.30k.
Cash flow per share | -5.92 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.6142 |
---|---|
Tangible book value per share | 0.6142 |
More ▼
Balance sheet in USDView more
Current ratio | 5.62 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼